This site is not optimized for Internet Explorer 8 (or older).

Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.

Multi-Institutional Analysis of 200 COVID-19 Patients Treated With ECMO: Outcomes and Trends

Monday, July 12, 2021

Submitted by


Source Name: The Annals of Thoracic Surgery


Jeffrey P. Jacobs, MD, Alfred H. Stammers, MSA, James D. St. Louis, MD, J.W. Awori Hayanga, MD, Michael S. Firstenberg, MD, Linda B. Mongero, CCP, Eric A. Tesdahl, PhD, Keshava Rajagopal, MD, PhD, Faisal H. Cheema, MD, Kirti Patel, CCP, Tom Coley, CCP, Anthony K. Sestokas, PhD, Marvin J. Slepian, MD, Vinay Badhwar, MD

In this article, Jacobs et al. provide a multi-institutional outcomes review of 200 consecutive patients with confirmed COVID-19 supported with ECMO. The mean time on ECMO was 15 days with survival on VV-ECMO of 46.3% and survival on VA-ECMO of 25%. Predictors of survival included a lower median age and shorter median time from COVID-19 diagnosis to ECMO initiation.

Add comment

Log in or register to post comments